Skip to main
SENS
SENS logo

Senseonics Holdings (SENS) Stock Forecast & Price Target

Senseonics Holdings (SENS) Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 42%
Buy 17%
Hold 25%
Sell 8%
Strong Sell 8%

Bulls say

Senseonics Holdings Inc. has demonstrated significant revenue growth potential, reporting $8.3 million in revenue for the fourth quarter of 2024, contributing to a total of $22.5 million for fiscal year 2024. The approval and launch of the Eversense 365 continuous glucose monitor drove a remarkable 56% increase in the patient base, reaching approximately 6,000 global patients, which underscores the strong market acceptance and potential for patient acquisition. Additionally, early feedback from patients and clinicians has been overwhelmingly positive, with lead generation exceeding expectations by over 200% in the month following the product's approval, suggesting a promising trajectory for sustained revenue growth moving into 2025.

Bears say

Senseonics Holdings, Inc. reported a net loss of $15.5 million in 4Q24, an improvement from a $24.0 million loss in 3Q24, but still exceeds earnings forecasts, highlighting continued operational challenges. The company's business model faces significant risks, including stringent regulatory requirements for clinical studies, reliance on the success of its global commercialization partner, Ascensia Diabetes Care, and potential intellectual property issues that could hinder competitive advantages. Furthermore, concerns over market conditions impacting fundraising efforts and the possibility of poor stock performance leading to failure to meet Nasdaq listing requirements contribute to an unfavorable outlook for the company's financial stability.

Senseonics Holdings (SENS) has been analyzed by 12 analysts, with a consensus rating of Buy. 42% of analysts recommend a Strong Buy, 17% recommend Buy, 25% suggest Holding, 8% advise Selling, and 8% predict a Strong Sell.

This aggregate rating is based on analysts' research of Senseonics Holdings and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Senseonics Holdings (SENS) Forecast

Analysts have given Senseonics Holdings (SENS) a Buy based on their latest research and market trends.

According to 12 analysts, Senseonics Holdings (SENS) has a Buy consensus rating as of Jun 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $2.52, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $2.52, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Senseonics Holdings (SENS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.